Edesa BiotechEDSA
13F holders, Q1 2024 (March 31)17holders
$4.18avg. 13F price*
At the end of Q1 2024, 17 institutions reported holding Edesa Biotech Inc. (EDSA) in their 13F filings. The largest holders were CM Management, LLC ($260K), Vanguard Group Inc. ($66K) and Geode Capital Management, LLC ($60K).
- Company
- Edesa Biotech Inc.
- CUSIP
- 27966L306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $589 |
| Exits | 3 | $379 |
Ownership 17 holders
| CM Management, LLC | 0.22% | No change | 62,000 | $260K |
| Vanguard Group Inc. | 0.00% | Reduce -2.9% | 15,864 | $66K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.0% | 14,385 | $60K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,333 | $47K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +32.6% | 2,074 | $9K |
| Royal Bank of Canada | 0.00% | Add +700.5% | 1,737 | $7K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 142 | $611 |
| FMR LLC | 0.00% | New | 142 | $589 |
| Fifth Third Bancorp | 0.00% | No change | 100 | $419 |
| Morgan Stanley | 0.00% | No change | 28 | $117 |
| Global Retirement Partners, LLC | 0.00% | No change | 25 | $105 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 19 | $80 |
| Wells Fargo & Company | 0.00% | Add +6.3% | 17 | $71 |
| National Bank of Canada | 0.00% | No change | 8 | $36 |
| UBS Group AG | 0.00% | Reduce -99.9% | 4 | $17 |
| Credit Agricole S A | 0.00% | No change | 1 | $4 |
| AllSquare Wealth Management LLC | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is EDSA's weight in each manager's 13F, not the share of Edesa Biotech Inc. the manager owns.